These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15816522)

  • 1. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
    Takayama S; Ishii S; Ikeda T; Masamura S; Doi M; Kitajima M
    Anticancer Res; 2005; 25(1A):79-83. PubMed ID: 15816522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
    Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
    Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
    Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
    Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.
    Pécheur I; Peyruchaud O; Serre CM; Guglielmi J; Voland C; Bourre F; Margue C; Cohen-Solal M; Buffet A; Kieffer N; Clézardin P
    FASEB J; 2002 Aug; 16(10):1266-8. PubMed ID: 12153995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
    Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
    Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
    Vellon L; Menendez JA; Liu H; Lupu R
    Differentiation; 2007 Nov; 75(9):819-30. PubMed ID: 17999741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
    Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
    Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
    Gasparini G; Brooks PC; Biganzoli E; Vermeulen PB; Bonoldi E; Dirix LY; Ranieri G; Miceli R; Cheresh DA
    Clin Cancer Res; 1998 Nov; 4(11):2625-34. PubMed ID: 9829725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit.
    Baum O; Hlushchuk R; Forster A; Greiner R; Clézardin P; Zhao Y; Djonov V; Gruber G
    Int J Oncol; 2007 Feb; 30(2):325-32. PubMed ID: 17203213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of integrin siRNA and irradiation for breast cancer therapy.
    Cao Q; Cai W; Li T; Yang Y; Chen K; Xing L; Chen X
    Biochem Biophys Res Commun; 2006 Dec; 351(3):726-32. PubMed ID: 17087916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bidirectional "alpha(v)beta(3) integrin-ERK1/ERK2 MAPK" connection regulates the proliferation of breast cancer cells.
    Vellon L; Menendez JA; Lupu R
    Mol Carcinog; 2006 Oct; 45(10):795-804. PubMed ID: 16705745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
    van der Pluijm ; Vloedgraven H; Papapoulos S; Löwick C; Grzesik W; Kerr J; Robey PG
    Lab Invest; 1997 Dec; 77(6):665-75. PubMed ID: 9426405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant.
    Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T
    Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
    Harms JF; Welch DR; Samant RS; Shevde LA; Miele ME; Babu GR; Goldberg SF; Gilman VR; Sosnowski DM; Campo DA; Gay CV; Budgeon LR; Mercer R; Jewell J; Mastro AM; Donahue HJ; Erin N; Debies MT; Meehan WJ; Jones AL; Mbalaviele G; Nickols A; Christensen ND; Melly R; Beck LN; Kent J; Rader RK; Kotyk JJ; Pagel MD; Westlin WF; Griggs DW
    Clin Exp Metastasis; 2004; 21(2):119-28. PubMed ID: 15168729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
    Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.